Author(s): Talib Abbas
Abstract Share this page
Type 2 diabetes has been identified as a risk factor for Alzheimer disease (AD). Insulin signalling is often impaired in AD, contributing to the neurodegeneration seen in AD. Previous studies have shown that the incretin glucagon-like peptide 1 (GLP-1) helps to normalise insulin signalling in type 2 diabetes.
This article was published in Behav Brian Res
and referenced in Journal of Biomolecular Research & Therapeutics